|
|
canonical wnt signaling pathway involved in cardiac muscle cell fate commitment
|
GO:0061317 |
3 |
1.000
|
|
|
|
secondary heart field specification
|
GO:0003139 |
2 |
0.990
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003256 |
3 |
0.986
|
|
|
|
nephric duct development
|
GO:0072176 |
4 |
0.900
|
|
|
|
canonical wnt signaling pathway involved in heart development
|
GO:0061316 |
3 |
0.782
|
|
|
|
regulation of wnt signaling pathway involved in heart development
|
GO:0003307 |
3 |
0.781
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.688
|
|
|
|
cardiac muscle cell fate commitment
|
GO:0060923 |
4 |
0.639
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
1 |
0.560
|
|
|
|
determination of left right asymmetry in lateral mesoderm
|
GO:0003140 |
1 |
0.553
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.534
|
|
|
|
regulation of cardiac muscle cell differentiation
|
GO:2000725 |
7 |
0.527
|
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
2 |
0.486
|
|
|
|
sebaceous gland development
|
GO:0048733 |
1 |
0.480
|
|
|
|
lung cell differentiation
|
GO:0060479 |
1 |
0.459
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.422
|
|
|
|
pronephric nephron development
|
GO:0039019 |
1 |
0.420
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.419
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
1 |
0.379
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.361
|
|
|
|
positive regulation of cardiac muscle cell differentiation
|
GO:2000727 |
4 |
0.346
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.338
|
|
|
|
cardiac muscle cell myoblast differentiation
|
GO:0060379 |
5 |
0.333
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.304
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.303
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.302
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
1 |
0.267
|
|
|
|
memory
|
GO:0007613 |
3 |
0.264
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.262
|
|
|
|
hair follicle maturation
|
GO:0048820 |
3 |
0.232
|
|
|
|
inflammatory response to antigenic stimulus
|
GO:0002437 |
4 |
0.231
|
|
|
|
endocardial cushion development
|
GO:0003197 |
3 |
0.221
|
|
|
|
heart field specification
|
GO:0003128 |
2 |
0.212
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.208
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
3 |
0.203
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
4 |
0.197
|
|
|
|
epithelial cell fate commitment
|
GO:0072148 |
3 |
0.190
|
|
|
|
muscle cell fate commitment
|
GO:0042693 |
4 |
0.182
|
|
|
|
mesodermal cell fate specification
|
GO:0007501 |
2 |
0.171
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
3 |
0.156
|
|
|
|
long term memory
|
GO:0007616 |
2 |
0.154
|
|
|
|
positive regulation of heart growth
|
GO:0060421 |
2 |
0.149
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.149
|
|
|
|
hair cell differentiation
|
GO:0035315 |
2 |
0.144
|
|
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.138
|
|
|
|
glomerular epithelial cell differentiation
|
GO:0072311 |
5 |
0.134
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.134
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.133
|
|
|
|
lung epithelium development
|
GO:0060428 |
7 |
0.132
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.130
|
|
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.129
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.126
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.125
|
|
|
|
lateral mesoderm development
|
GO:0048368 |
1 |
0.125
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.123
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
2 |
0.119
|
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.117
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.113
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.109
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
4 |
0.108
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
4 |
0.104
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.102
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
2 |
0.102
|
|
|
|
i kappab phosphorylation
|
GO:0007252 |
7 |
0.102
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.101
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.099
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.094
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.091
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.091
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.090
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
2 |
0.087
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.086
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.086
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901213 |
6 |
0.086
|
|
|
|
glomerular visceral epithelial cell differentiation
|
GO:0072112 |
4 |
0.083
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
1 |
0.083
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.081
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.081
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.079
|
|
|
|
vitamin d receptor signaling pathway
|
GO:0070561 |
4 |
0.078
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.077
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.076
|
|
|
|
regulation of glycolytic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072361 |
2 |
0.076
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.076
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.075
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.075
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.074
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.074
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.074
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.074
|
|
|
|
pericardium development
|
GO:0060039 |
2 |
0.074
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.072
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.072
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.071
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.071
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.071
|
|
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
15 |
0.071
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
7 |
0.070
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.070
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
2 |
0.069
|
|
|
|
cardiac left ventricle morphogenesis
|
GO:0003214 |
6 |
0.069
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.069
|
|
|
|
hair cycle
|
GO:0042633 |
28 |
0.067
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.067
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.065
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.064
|
|
|
|
endocardium development
|
GO:0003157 |
2 |
0.063
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
1 |
0.063
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.063
|
|
|
|
positive regulation of cell fate specification
|
GO:0042660 |
2 |
0.062
|
|
|
|
system process
|
GO:0003008 |
349 |
0.062
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.061
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.061
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.061
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.061
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.060
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.060
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.060
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.059
|
|
|
|
aortic valve development
|
GO:0003176 |
3 |
0.059
|
|
|
|
regulation of muscle cell differentiation
|
GO:0051147 |
31 |
0.058
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.057
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.055
|
|
|
|
endothelial cell fate commitment
|
GO:0060839 |
3 |
0.054
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.054
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.054
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.054
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.054
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.054
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.054
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.053
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.052
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.052
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
2 |
0.050
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.049
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.049
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.048
|
|
|
|
cardiac conduction system development
|
GO:0003161 |
2 |
0.048
|
|
|
|
regulation of cell proliferation involved in heart morphogenesis
|
GO:2000136 |
1 |
0.048
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.048
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.047
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.047
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.047
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
1 |
0.047
|
|
|
|
wnt signaling pathway involved in heart development
|
GO:0003306 |
5 |
0.047
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.047
|
|
|
|
cell proliferation involved in heart morphogenesis
|
GO:0061323 |
1 |
0.046
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.046
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.046
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.045
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.045
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.045
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.045
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
13 |
0.045
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.044
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.044
|
|
|
|
pronephros development
|
GO:0048793 |
2 |
0.044
|
|
|
|
respiratory tube development
|
GO:0030323 |
20 |
0.044
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.044
|
|
|
|
mitral valve development
|
GO:0003174 |
3 |
0.044
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.043
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.043
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.042
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.042
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.042
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
26 |
0.042
|
|
|
|
regulation of mesodermal cell fate specification
|
GO:0042661 |
2 |
0.042
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.042
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.041
|
|
|
|
interleukin 4 production
|
GO:0032633 |
7 |
0.041
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.040
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.040
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
9 |
0.040
|
|
|
|
inflammatory response
|
GO:0006954 |
79 |
0.040
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.040
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.039
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.039
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.039
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.039
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
29 |
0.038
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.037
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.037
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.037
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.036
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.036
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.035
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.035
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.035
|
|
|
|
lung development
|
GO:0030324 |
20 |
0.035
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
15 |
0.035
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
41 |
0.035
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.034
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.034
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.034
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.034
|
|
|
|
hair cycle process
|
GO:0022405 |
12 |
0.033
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
9 |
0.033
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.033
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.033
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.033
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.033
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.033
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.033
|
|
|
|
negative regulation of endothelial cell chemotaxis
|
GO:2001027 |
4 |
0.032
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.032
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.032
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.032
|
|
|
|
cardiac vascular smooth muscle cell differentiation
|
GO:0060947 |
2 |
0.031
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.031
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.031
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
9 |
0.031
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.031
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.031
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.030
|
|
|
|
nephron epithelium development
|
GO:0072009 |
23 |
0.030
|
|
|
|
dendritic cell differentiation
|
GO:0097028 |
13 |
0.029
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.029
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.029
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.029
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.029
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.029
|
|
|
|
aorta development
|
GO:0035904 |
2 |
0.029
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.028
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.028
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.028
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.028
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.028
|
|
|
|
respiratory system development
|
GO:0060541 |
22 |
0.028
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.028
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.028
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.028
|
|
|
|
exocytosis
|
GO:0006887 |
71 |
0.028
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.027
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.027
|
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.027
|
|
|
|
lipid transport
|
GO:0006869 |
90 |
0.027
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.027
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.027
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.027
|
|
|
|
glomerulus development
|
GO:0032835 |
15 |
0.026
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.026
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.026
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.026
|
|
|
|
glomerular epithelium development
|
GO:0072010 |
7 |
0.026
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.026
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.026
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.026
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.025
|
|
|
|
distal tubule development
|
GO:0072017 |
4 |
0.025
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.025
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
6 |
0.025
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.025
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.025
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.025
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.025
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.025
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.025
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.025
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.025
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.025
|
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
3 |
0.024
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.024
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.024
|
|
|
|
regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072366 |
1 |
0.024
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.024
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.024
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.024
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.024
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.024
|
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.024
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.024
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.024
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
19 |
0.023
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.023
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.023
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.023
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061419 |
2 |
0.023
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.023
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.023
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.023
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.023
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
44 |
0.023
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.023
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.023
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
27 |
0.022
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.022
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.022
|
|
|
|
kidney epithelium development
|
GO:0072073 |
25 |
0.022
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.022
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.022
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.022
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.022
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.022
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.022
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.022
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.022
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.022
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.021
|
|
|
|
intracellular bile acid receptor signaling pathway
|
GO:0038185 |
1 |
0.021
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
21 |
0.021
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.021
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.021
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.021
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.021
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.021
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.021
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
2 |
0.021
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.021
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.021
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.021
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.021
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
3 |
0.020
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.020
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.020
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.020
|
|
|
|
rna splicing
|
GO:0008380 |
131 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.020
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.020
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.020
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.020
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.020
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
34 |
0.020
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.020
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.019
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.019
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.019
|
|
|
|
positive regulation of cardiac muscle tissue development
|
GO:0055025 |
6 |
0.019
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.019
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.019
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.019
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.019
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.019
|
|
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.019
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
20 |
0.019
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.019
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.019
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.019
|
|
|
|
head development
|
GO:0060322 |
108 |
0.019
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.019
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.019
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.019
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.019
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.018
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.018
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.018
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.018
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.018
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.018
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.018
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
14 |
0.018
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.018
|
|
|
|
b cell activation
|
GO:0042113 |
33 |
0.018
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.018
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.018
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.018
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.018
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.018
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.018
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.017
|
|
|
|
heart valve formation
|
GO:0003188 |
2 |
0.017
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.017
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.017
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.017
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.017
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.017
|
|
|
|
regulation of glial cell proliferation
|
GO:0060251 |
4 |
0.017
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.017
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.017
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.017
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.017
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.017
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.017
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.017
|
|
|
|
visual learning
|
GO:0008542 |
1 |
0.017
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.016
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.016
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.016
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.016
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.016
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.016
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.016
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.016
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.016
|
|
|
|
positive regulation of interleukin 5 production
|
GO:0032754 |
3 |
0.016
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
15 |
0.016
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.016
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.016
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.016
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
26 |
0.016
|
|
|
|
regulation of lipid transport by regulation of transcription from rna polymerase ii promoter
|
GO:0072367 |
4 |
0.016
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.016
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
14 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.016
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.016
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.016
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.016
|
|
|
|
regulation of organ growth
|
GO:0046620 |
7 |
0.016
|
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
3 |
0.016
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
1 |
0.016
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.016
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.015
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.015
|
|
|
|
t helper 2 cell differentiation
|
GO:0045064 |
1 |
0.015
|
|
|
|
muscle organ morphogenesis
|
GO:0048644 |
19 |
0.015
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.015
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.015
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
19 |
0.015
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
3 |
0.015
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.015
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.015
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.015
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.015
|
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
15 |
0.015
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.015
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.015
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.015
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.015
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.015
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
0.015
|
|
|
|
nephron development
|
GO:0072006 |
30 |
0.015
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.015
|
|
|
|
mating
|
GO:0007618 |
1 |
0.015
|
|
|
|
positive regulation of muscle organ development
|
GO:0048636 |
7 |
0.015
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.015
|
|
|
|
venous blood vessel development
|
GO:0060841 |
2 |
0.014
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.014
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.014
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
81 |
0.014
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.014
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.014
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.014
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.014
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.014
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.014
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.014
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.014
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.014
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.014
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.014
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
89 |
0.014
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
19 |
0.014
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.014
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.014
|
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.014
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.014
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.014
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
1 |
0.014
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
18 |
0.014
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.014
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.014
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.014
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.014
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.014
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.014
|
|
|
|
growth
|
GO:0040007 |
202 |
0.013
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.013
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.013
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
42 |
0.013
|
|
|
|
extracellular structure organization
|
GO:0043062 |
41 |
0.013
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.013
|
|
|
|
negative regulation of bile acid biosynthetic process
|
GO:0070858 |
3 |
0.013
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
4 |
0.013
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.013
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.013
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
3 |
0.013
|
|
|
|
molting cycle
|
GO:0042303 |
28 |
0.013
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
62 |
0.013
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.013
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.013
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.013
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
84 |
0.013
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.013
|
|
|
|
myoblast differentiation
|
GO:0045445 |
21 |
0.013
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.013
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.013
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
56 |
0.013
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.013
|
|
|
|
mrna processing
|
GO:0006397 |
133 |
0.013
|
|
